A Company with Zero Revenue Conducts an IPO on Nasdaq In May of this year (2018), a Singaporean pharmaceutical company, ASLAN Pharmaceuticals, conducted an IPO on Nasdaq. For the 2017 fiscal period immediately preceding its IPO, ASLAN had zero consolidated revenue and a pre-tax loss of $40 million (approx. 4.0 billion JPY, converted at $1=100 … Continue reading A Guide to the US Capital Markets for Japanese Companies Vol.4